Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Report uncovers the barriers to disease control
IFAH calls for a joint approach to overcome key issues

Joint efforts are needed to minimise the risks of emerging and re-emerging animals diseases, according to a report by the International Federation for Animal Health (IFAH).

The report, titled "Emerging and re-emerging animal diseases - barriers to disease control", launched at a stakeholder event held at the Royal Society in London.

It concludes that further investment is needed in education, research and institutional effectiveness - both locally and globally - in order to reduce the risks to animal and human health and encourage long-term economic growth.

Three dominant barriers to effective disease control are examined in the report - barriers to research and development; barriers to commercialisation; and barriers to the use of veterinary medicines.

IFAH commissioned global analysis and advisory firm, Oxford Analytica, who were supported by a group of independent experts in animal health, to examine these barriers.

Key barriers to research were the high cost of developing medicines and a lack of veterinary experts to carry out diagnostic controls, leading to inefficiencies in responses to disease outbreaks. Additionally, the development of vaccines was found to be hindered by the constantly changing nature of virus strains.

According to the report, overly burdensome regulations and lack of streamlined approval processes cause delays and increase costs of bringing veterinary medicines to market.

Furthermore, the use of veterinary medicines was found to be facing a lack of government support and logistical problems in the distribution and availability of the medicines.

Mike McGowan, IFAH's acting executive director and programme chair, noted that rapid increases in the human population and wealth have led to unprecedented demand for livestock products. The risk of further serious epidemics will grow, he says, as pathogens evolve and mutate.

Given that 75 per cent of emerging animal diseases are zoonotic, Mr McGowan stressed that this will impact both animal and human health.

"IFAH commissioned this white paper as a launch point for wider collaborative discussions with international stakeholders on what future efforts would be required to overcome barriers that limit our ability to control emerging and re-emerging diseases," Mr McGowan said.

"Regulatory harmonisation, empowering veterinarians, public-private partnerships and cooperation between the animal and human health sectors are vital to ensure that we can respond to and control disease outbreaks."

The full report can be downloaded here.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.